Deep Vein Thrombosis and Malignancy: A Surgical Oncologist's Perspective

Smith, 1994, Emergencies in palliative care, Ann Acad Med Singapore, 23, 186 Siegal, 1995, Spinal cord compression: from laboratory to clinic, Eur J Cancer, 31A, 1748, 10.1016/0959-8049(95)00320-I Coleman, 1997, Skeletal complications of malignancy, Cancer, 80, 1588, 10.1002/(SICI)1097-0142(19971015)80:8+<1588::AID-CNCR9>3.0.CO;2-G Scher, 1987, Bone metastases: pathogenesis, treatment, and rationale for use of resorption inhibitors, Am J Med, 82, 6, 10.1016/0002-9343(87)90483-9 Nelson, 2000, Common complications of advanced cancer, Semin Oncol, 27, 34 DeCamp, 1997, Malignant effusive disease of the pleura and pericardium, Chest, 112, 291S, 10.1378/chest.112.4_Supplement.291S Fenton, 1995, Diagnosis and management of malignant pleural effusions, Am J Surg, 170, 69, 10.1016/S0002-9610(99)80257-8 Shepherd, 1997, Malignant pericardial effusion, Curr Opin Oncol, 9, 170, 10.1097/00001622-199703000-00011 Chen, 1983, Extracardiac malignancy presenting with cardiac tam-ponade, J Surg Oncol, 23, 167, 10.1002/jso.2930230308 Zapf, 1993, Role of insulin-like growth factor (IGF) II and IGF binding proteins in extrapancreatic tumour hypoglycaemia, J Intern Med, 234, 543, 10.1111/j.1365-2796.1993.tb01012.x Phillips, 1993, Insulin-like growth factors and non-islet cell tumor hypoglycemia, Metabolism, 42, 1093, 10.1016/0026-0495(93)90265-P Sorensen, 1995, Syndrome of inappropriate secretion of antidiuretic hormone (SIADH) in malignant disease, J Intern Med, 238, 97, 10.1111/j.1365-2796.1995.tb00907.x Silverman, 1989, Metabolic emergencies in clinical oncology, Semin Oncol, 16, 504 Stolinsky, 1983, Trousseau's phenomenon, Blood, 62, 1304, 10.1182/blood.V62.6.1304a.1304a Clagett, 1994, Prevention of postoperative venous thromboembolism: an update, Am J Surg, 168, 515, 10.1016/S0002-9610(05)80114-X Flinn, 1996, Prospective surveillance for perioperative venous thrombosis, Arch Surg, 131, 472, 10.1001/archsurg.1996.01430170018002 Tai, 1999, Modern management of pulmonary embolism, Br J Surg, 86, 853, 10.1046/j.1365-2168.1999.01158.x Perkins, 1996, Phlegmasia caerulea dolens and venous gangrene, Br J Surg, 83, 19, 10.1002/bjs.1800830106 Kahn, 2002, The post-thrombotic syndrome: current knowledge, controversies and directions for future research, Blood Rev, 16, 155, 10.1016/S0268-960X(02)00008-5 Silver, 2000, The caput medusae of hypercoagulability, J Vasc Surg, 31, 396, 10.1016/S0741-5214(00)90170-8 Mammen, 1992, Pathogenesis of venous thrombosis, Chest, 102, 640S, 10.1378/chest.102.6_Supplement.640S Estrov, 1995, Elevated plasma thrombopoietic activity in patients with metastatic cancer-related thrombocytosis, Am J Med, 98, 551, 10.1016/S0002-9343(99)80013-8 Heinmoller, 1996, Studies on tumor-cell-induced platelet aggregation in human lung cancer cell lines, J Cancer Res Clin Oncol, 122, 735, 10.1007/BF01209121 Tohgo, 1986, Platelet-aggregating activities of metastasizing tumor cells: effects of cell surface modification on thrombin generation, platelet aggregation and subsequent lung colonization, Invasion Metastasis, 6, 58 Zhang, 1994, Tissue factor controls the balance of angiogenic and antiangiogenic properties of tumor cells in mice, J Clin Invest, 94, 1320, 10.1172/JCI117451 Levine, 1998, Treatment of venous thromboembolism in cancer patients, Haemostasis, 28, 66 1993, 336 Anderson, 2003, Risk factors for venous thrombo-embolism, Circulation, 107, I9 Geerts, 2001, Prevention of venous thromboembolism, Chest, 119, 132S, 10.1378/chest.119.1_suppl.132S Rosendaal, 1999, Venous thrombosis: a multicausal disease, Lancet, 353, 1167, 10.1016/S0140-6736(98)10266-0 Lipton, 1984, Venous thrombosis as a side effect of tamoxifen treatment, Cancer Treat Rep, 68, 887 Pritchard, 1996, Increased thromboem-bolic complications with concurrent tamoxifen and chemotherapy in a randomized trial of adjuvant therapy for women with breast cancer. National Cancer Institute of Canada Clinical Trials Group Breast Cancer Site Group, J Clin Oncol, 14, 2731, 10.1200/JCO.1996.14.10.2731 Saphner, 1991, Venous and arterial thrombosis in patients who received adjuvant therapy for breast cancer, J Clin Oncol, 9, 286, 10.1200/JCO.1991.9.2.286 Levine, 1988, The thrombogenic effect of anticancer drug therapy in women with stage II breast cancer, N Engl J Med, 318, 404, 10.1056/NEJM198802183180703 Graf, 1998, Oral anticoagulation in patients with gynecological cancer and radiotherapy: a retrospective analysis of 132 patients, Anticancer Res, 18, 2047 Schreiber, 1986, Axillary-subclavian vein thrombosis following combination chemotherapy and radiation therapy in lymphoma, Int J Radiat Oncol Biol Phys, 12, 391, 10.1016/0360-3016(86)90356-1 Sorensen, 1998, The risk of a diagnosis of cancer after primary deep venous thrombosis or pulmonary embolism, N Engl J Med, 338, 1169, 10.1056/NEJM199804233381701 Baron, 1998, Venous thromboembolism and cancer, Lancet, 351, 1077, 10.1016/S0140-6736(97)10018-6 Lieberman, 1961, Thrombophlebitis and cancer, JAMA, 177, 542, 10.1001/jama.1961.03040340006002 Sproul, 1938, Carcinoma and venous thrombosis: the frequency of association of carcinoma in the body or tail of the pancreas with multiple venous thrombosis, Am J Cancer, 34, 566 Lee, 2000, Deep vein thrombosis after major spinal surgery: incidence in an East Asian population, Spine, 25, 1827, 10.1097/00007632-200007150-00014 Ting, 2002, Perioperative deep vein thrombosis in Chinese patients undergoing craniotomy, Surg Neurol, 58, 274, 10.1016/S0090-3019(02)00842-X Klatsky, 2000, Risk of pulmonary embolism and/or deep venous thrombosis in Asian-Americans, Am J Cardiol, 85, 1334, 10.1016/S0002-9149(00)00766-9 White, 1998, Incidence of idiopathic deep venous thrombosis and secondary thromboembolism among ethnic groups in California, Ann Intern Med, 128, 737, 10.7326/0003-4819-128-9-199805010-00006 Dhillon, 1996, Postoperative deep-vein thrombosis in Asian patients is not a rarity: a prospective study of 88 patients with no prophylaxis, J Bone Joint Surg Br, 78, 427, 10.1302/0301-620X.78B3.0780427 Kum, 1993, Deep vein thrombosis complicating colorectal surgery in the Chinese in Singapore, Ann Acad Med Singapore, 22, 895 Nandi, 1998, Deep vein thrombosis and pulmonary embolism in the Chinese population, Hong Kong Med J, 4, 305 Ho, 1999, Randomized, controlled trial of low molecular weight heparin vs. no deep vein thrombosis prophylaxis for major colon and rectal surgery in Asian patients, Dis Colon Rectum, 42, 196, 10.1007/BF02237127 Hettiarachchi, 1998, Undiagnosed malignancy in patients with deep vein thrombosis, Cancer, 83, 180, 10.1002/(SICI)1097-0142(19980701)83:1<180::AID-CNCR24>3.0.CO;2-S Prandoni, 1992, Deep-vein thrombosis and the incidence of subsequent symptomatic cancer, N Engl J Med, 327, 1128, 10.1056/NEJM199210153271604 Nordstrom, 1994, Deep venous thrombosis and occult malignancy: an epidemiological study, BMJ, 308, 891, 10.1136/bmj.308.6933.891 Lensing, 1999, Deep-vein thrombosis, Lancet, 353, 479, 10.1016/S0140-6736(98)04298-6 Hull, 1992, Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis, N Engl J Med, 326, 975, 10.1056/NEJM199204093261502 Kearon, 2001, Duration of anticoagulation for venous thromboem-bolism, J Thromb Thrombolysis, 12, 59, 10.1023/A:1012790511790 Levine, 2002, Managing thromboembolic disease in the cancer patients: efficacy and safety of antithrombotic treatment options in patients with cancer, Cancer Treat Rev, 28, 145, 10.1016/S0305-7372(02)00042-7 Gallus, 2002, New aspects of the blood coagulation cascade, anticoagulants and vein thrombosis in Asia, Ann Acad Med Singapore, 31, 685 Decousus, 1998, A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prevention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group, N Engl J Med, 338, 409, 10.1056/NEJM199802123380701 Ihnat, 1998, Treatment of patients with venous thromboembolism and malignant disease: should vena cava filter placement be routine?, J Vasc Surg, 28, 800, 10.1016/S0741-5214(98)70054-0 Evans, 1996, Trousseau's syndrome in association with ovarian carcinoma, Cancer, 77, 2544, 10.1002/(SICI)1097-0142(19960615)77:12<2544::AID-CNCR18>3.0.CO;2-S Olin, 1987, Treatment of deep vein thrombosis and pulmonary emboli in patients with primary and meta-static brain tumors. Anticoagulants or inferior vena cava filter?, Arch Intern Med, 147, 2177, 10.1001/archinte.1987.00370120113020 Lebeau, 1994, Subcutaneous heparin treatment increases survival in small cell lung cancer. “Petites Cellules” Group, Cancer, 74, 38, 10.1002/1097-0142(19940701)74:1<38::AID-CNCR2820740108>3.0.CO;2-E Engelberg, 1999, Actions of heparin that may affect the malignant process, Cancer, 85, 257, 10.1002/(SICI)1097-0142(19990115)85:2<257::AID-CNCR1>3.0.CO;2-2 Prandoni, 1992, Comparison of subcutaneous low-molecular-weight heparin with intravenous standard heparin in proximal deep-vein thrombosis, Lancet, 339, 441, 10.1016/0140-6736(92)91054-C Green, 1992, Lower mortality in cancer patients treated with low-molecular-weight versus standard heparin, Lancet, 339, 1476, 10.1016/0140-6736(92)92064-M Bauer, 2000, Venous thromboembolism in malignancy, J Clin Oncol, 18, 3065, 10.1200/JCO.2000.18.17.3065 Palmer, 1997, Efficacy and safety of low molecular weight heparin, unfractionated heparin and warfarin for thromboembolism prophylaxis in orthopaedic surgery: a meta-analysis of randomised clinical trials, Haemostasis, 27, 75 Kakkar, 1993, Low molecular weight versus standard heparin for prevention of venous thromboembo-lism after major abdominal surgery, Lancet, 341, 259, 10.1016/0140-6736(93)92614-Y Levine, 1994, Double-blind randomised trial of very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer, Lancet, 343, 886, 10.1016/S0140-6736(94)90008-6 Hylek, 2001, Thromboembolic disease and anticoagulation in the elderly, Clin Geriatr Med, 17, 1, 10.1016/S0749-0690(05)70102-6